New options for testing and treating common sexually transmitted infections (STIs) are emerging in the United States, with experts hopeful these developments will curb national infection rates.
Last year, the Food and Drug Administration (FDA) approved the first at-home test for three prevalent infections in women – gonorrhoea, chlamydia, and trichomoniasis – and the first home-based kit for the virus causing cervical cancer.
